---
// src/pages/evidence.astro
import BaseLayout from "../layouts/BaseLayout.astro";
import { useTranslations } from "../i18n";

const t = useTranslations('en');
---

<BaseLayout 
  title={t.nav.evidence}
  description="Evidence supporting the Axonal Highway Hypothesis: epidemiological data, genetic associations, and laboratory findings."
>
  <section class="bg-gradient-to-b from-slate-900 to-slate-800 text-white py-16">
    <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
      <nav class="text-sm text-slate-400 mb-4">
        <a href="/" class="hover:text-white transition-colors">Home</a>
        <span class="mx-2">/</span>
        <span class="text-white">Evidence</span>
      </nav>
      <h1 class="text-4xl md:text-5xl font-bold mb-4">Supporting Evidence</h1>
      <p class="text-xl text-slate-300 max-w-3xl">
        Multiple lines of evidence converge to support the Axonal Highway Hypothesis.
      </p>
    </div>
  </section>

  <section class="py-12">
    <div class="max-w-4xl mx-auto px-4 sm:px-6 lg:px-8">
      <div class="prose-science">
        
        <h2>Epidemiological Evidence</h2>
        <p>
          The association between Pandemrix and narcolepsy was first identified in Nordic countries 
          and has since been confirmed worldwide. Key findings include:
        </p>
        <ul>
          <li>6-13 fold increased risk of narcolepsy following Pandemrix vaccination</li>
          <li>Onset typically 2-8 months post-vaccination</li>
          <li>Primarily affected children and adolescents</li>
          <li>Association not seen with other H1N1 vaccines (Focetria, Celvapan)</li>
        </ul>

        <h2>Genetic Evidence</h2>
        <p>
          Nearly all affected individuals carry the HLA-DQB1*06:02 allele. While this supports 
          autoimmune etiology, the mechanism involves <strong>three linked genes</strong> in the 
          MHC region — the "Synergistic Trinity":
        </p>
        
        <div class="bg-slate-800 text-white rounded-lg p-6 my-6">
          <h4 class="font-bold text-cyan-400 mb-4">The Synergistic Trinity</h4>
          <div class="grid md:grid-cols-3 gap-4">
            <div class="bg-slate-700 rounded p-4">
              <h5 class="font-bold text-purple-400 mb-2">HLA-DQB1*06:02</h5>
              <p class="text-slate-300 text-sm">The <strong>Lock</strong> — Presents mimicry peptides to T cells</p>
            </div>
            <div class="bg-slate-700 rounded p-4">
              <h5 class="font-bold text-cyan-400 mb-2">NEU1</h5>
              <p class="text-slate-300 text-sm">The <strong>Accumulator</strong> — Reduced degradation → more GT1b receptors</p>
            </div>
            <div class="bg-slate-700 rounded p-4">
              <h5 class="font-bold text-amber-400 mb-2">B3GALT4</h5>
              <p class="text-slate-300 text-sm">The <strong>Producer</strong> — Overproduces GT1b → exosome shedding</p>
            </div>
          </div>
        </div>

        <div class="key-concept">
          <div class="key-concept-title">NEU1: The "Lazy Enzyme" Evidence</div>
          <p class="mb-2">
            <strong>NEU1</strong> (Neuraminidase 1) at 6p21.33 degrades gangliosides by removing sialic acids. 
            GWAS shows NEU1 variants associated with narcolepsy at <strong>p = 6E-14</strong>.
          </p>
          <ul class="mb-0 text-sm">
            <li>• <strong>Key finding:</strong> NT1 patients have 3x elevated trisialylated N-glycans in serum</li>
            <li>• <strong>Interpretation:</strong> This indicates <em>reduced</em> NEU1 activity ("Lazy Enzyme")</li>
            <li>• <strong>Result:</strong> GT1b accumulates on nerve surfaces → more viral binding sites</li>
          </ul>
        </div>

        <div class="warning-box">
          <h4 class="font-bold text-amber-800 mb-2">Important Clarification: B3GALT4 ≠ N-Glycans</h4>
          <p class="text-amber-700 text-sm mb-0">
            NT1 patients show elevated <strong>trisialylated N-glycans</strong> in serum. This is NOT due to 
            B3GALT4 (which only makes gangliosides). The true driver is <strong>NEU1 dysfunction</strong> — 
            reduced degradation leads to hypersialylation. B3GALT4 affects the <em>ganglioside</em> pathway 
            (GT1b → viral binding), while NEU1 affects the <em>N-glycan</em> pathway (sialic acid catabolism).
          </p>
        </div>

        <h2>Laboratory Evidence</h2>
        <p>
          Several laboratory findings support the hypothesis:
        </p>
        <ul>
          <li>H1N1 hemagglutinin shows affinity for sialylated glycans including gangliosides</li>
          <li>Molecular mimicry between H1N1 nucleoprotein and orexin receptor 2 (HCRTR2)</li>
          <li>T-cell reactivity to H1N1 epitopes in narcolepsy patients</li>
          <li>Established precedent: tetanus toxin transport via GT1b</li>
        </ul>

        <h2>Neurotracing Evidence</h2>
        <p>
          Extensive research on retrograde axonal transport demonstrates:
        </p>
        <ol>
          <li>GT1b-binding molecules are efficiently transported from peripheral nerves to spinal cord</li>
          <li>Intraneuronal injection produces more efficient transport than perineuronal application</li>
          <li>Antibody-antigen complexes can be co-transported</li>
          <li>Some tracers (like tetanus toxin) are released into CNS parenchyma</li>
        </ol>

        <h2>The Complete Pathogenesis Model</h2>
        <p>
          Integrating all evidence, we propose an 8-step cascade from genetic predisposition to 
          orexin neuron destruction:
        </p>
        <ol>
          <li><strong>Genetic Predisposition:</strong> Individual inherits HLA-DQB1*06:02 + NEU1(High) + B3GALT4(High) haplotype</li>
          <li><strong>Trigger:</strong> H1N1 infection or Pandemrix vaccination</li>
          <li><strong>NEU1 "Lazy Enzyme":</strong> Reduced degradation → GT1b accumulates → more viral binding sites</li>
          <li><strong>Cytokine Storm:</strong> IL-1β, IL-6, TNF-α production via NF-κB</li>
          <li><strong>B3GALT4 Overdrive:</strong> GT1b overproduction, exosome shedding</li>
          <li><strong>Exosomal Adjuvans:</strong> GT1b-rich exosomes activate TLR2, amplify response</li>
          <li><strong>Antigen Presentation:</strong> NEU1 unmasks epitopes, HLA-DQB1 presents mimicry peptide</li>
          <li><strong>BBB Breach + Destruction:</strong> CD4+ T-cells enter hypothalamus, destroy orexin neurons</li>
        </ol>

        <div class="info-box">
          <h4 class="font-bold text-blue-800 mb-2">Explore the Full Model</h4>
          <p class="text-blue-700 text-sm mb-0">
            For detailed diagrams and complete explanations, see:
            <a href="/science/genetics/" class="text-blue-600 underline">Genetics</a> | 
            <a href="/science/transport/" class="text-blue-600 underline">Neuronal Transport</a> | 
            <a href="/science/gangliosides/" class="text-blue-600 underline">Ganglioside Biology</a>
          </p>
        </div>
      </div>
    </div>
  </section>
</BaseLayout>
